kenneth p. steinberg, MD
Division of Pulmonary and Critical Care Medicine
Director, Medicine Residency Program
University of Washington Medical Center
BB-527 Health Sciences Building
Seattle, WA 98195
Harborview Medical Center
325 Ninth Avenue, Campus Box 359762
Seattle, WA 98104
Clinician-Educator Web Page
Academic Office: (206) 543-3605; (206) 744-3356
Fax: (206) 685-8652
Clinic Appointments: (206) 744-3123
Education and Training
B.A., Colgate University, Hamilton, NY, 1981.
M.D., New York Medical College, Valhalla, NY, 1985.
Internship at Boston University,
Boston, MA, 1986.
Residency at Boston University,
Boston, MA 1988
Chief Medical Resident, The University Hospital, Boston University Medical Center,
Boston, MA, 1988-1989.
Fellowship in Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, 1992.
My objectives are to expand our understanding of the natural history and epidemiology of acute lung injury and the acute respiratory distress syndrome (ARDS). I am specifically interested in studying the risk factors, incidence, clinical course, predictors of mortality, causes of death, and the functional status of survivors of ARDS. I am also interested in investigating the evolution of the inflammatory process in the blood and the lung to better understand the pathogenesis of lung injury. Many of these studies utilize bronchoalveolar lavage fluid obtained from patients at risk for or with ARDS. Finally, I am very involved with investigating new treatment options for patients with, or at risk for, ALI and ARDS.
These investigations will allow early identification of patients at particularly high risk for development of ALI and ARDS, as well as identifying the inflammatory mechanisms involved and their time course, interactions, and correlation with clinical characteristics or events. These data are necessary for the appropriate design of clinical intervention trials. The ultimate goal of providing this information would be to enhance our ability to identify specific interventions which are likely to benefit patients at high risk for or with ALI and ARDS.
Steinberg KP, Mitchell DR, Maunder RJ, Milberg JA, Whitcomb ME, Hudson LD. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1993;148:556-61.
Steinberg KP, Milberg JA, Maunder RJ, Martin TR, Cockrill BA, Hudson LD. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med 1994;150:113-22.
Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995; 273:306-309. Sutherland KR, Steinberg KP, Maunder RJ, Milberg JA, Allen DL, Hudson LD. Pulmonary infection during the acute respiratory distress syndrome (ARDS). Am J Respir Crit Care Med 1995;152:550-556
Gregory TJ, Steinberg KP, Spragg RG, et al. Bovine surfactant therapy for patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 1997;155:1309-1315.
Davidson TA, Caldwell E, Curtis JR, Hudson LD, Steinberg KP. Reduced quality of life in survivors of acute respiratory distress syndrome compared to critically ill controls. JAMA 1999;281:354-360.